Rock Creek Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,000
Closed -$243K 134
2019
Q4
$243K Sell
15,000
-3,500
-19% -$56.7K 0.1% 110
2019
Q3
$241K Buy
18,500
+3,500
+23% +$45.6K 0.11% 96
2019
Q2
$195K Buy
+15,000
New +$195K 0.09% 102